Clinical Trial: A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy

U.S., Feb. 13 -- ClinicalTrials.gov registry received information related to the study (NCT06821542) titled 'A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy' on Feb. 06.

Brief Summary: This study will be conducted to compare Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy.

Study Start Date: June 30, 2025

Study Type: INTERVENTIONAL

Condition: Chronic Graft-versus-host-disease

Intervention: DRUG: INCA034176

IV infusion

DRUG: Best Available Therapy (BAT)

Best Available Therapy (BAT) will be selected by the Investigator for ...